Evidence map›Paper›PMID 20146356›Full record

ArticleGenesis (New York, N.Y. : 2000)2010

Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer.

Nicolas Currier, Kathleen Chea, Mirka Hlavacova, Daniel J Sussman, David C Seldin, Isabel Dominguez

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Monitoring Wnt/β-Catenin Signaling in Skin.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  10. Article
  11. Wnt-signalling in the embryonic mammary gland.Journal of mammary gland biology and neoplasia · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Wnt signaling in mammalian development: lessons from mouse genetics.Cold Spring Harbor perspectives in biology · 2012
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicolas CurrierDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Kathleen Chea
Mirka Hlavacova
Daniel J Sussman
David C Seldin
Isabel Dominguez
Boston University · USNew Horizons Diagnostics (United States) · US

Funding

Signaling Pathways in Stages of TumorigenesisP01ES011624 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SONENSHEIN, GAIL E. · 2001 to 2012
$11.4M
Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2R01CA071796 · NCI · BOSTON MEDICAL CENTER · PI SELDIN, DAVID C · 1997 to 2010
$2.8M
NCI NIH HHS R01 CA071796NCI NIH HHS R01 CA71796NIEHS NIH HHS P01 ES011624NIEHS NIH HHS P01 ES11624
6 · The paper itself

Abstract

We have characterized a transgenic mouse line in which enhanced green fluorescent protein (EGFP) is expressed under the control of multimerized LEF-1 responsive elements. In embryos, EGFP was detected in known sites of Wnt activation, including the primitive streak, mesoderm, neural tube, somites, heart, limb buds, mammary placodes, and whisker follicles. In vitro cultured transgenic embryonic fibroblasts upregulated EGFP expression in response to activation of Wnt signaling by GSK3beta inhibition. Mammary tumor cell lines derived from female LEF-EGFP transgenic mice treated with the carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA) also express EGFP. Thus, this transgenic line is useful for ex vivo and in vitro studies of Wnt signaling in development and cancer.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsbeta CateninCarcinogensCells, CulturedEmbryo, MammalianFemaleFibroblastsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGreen Fluorescent ProteinsImmunoblottingLymphoid Enhancer-Binding Factor 1MaleMammary Neoplasms, ExperimentalMice9,10-Dimethyl-1,2-benzanthracenebeta CateninCarcinogensGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGreen Fluorescent ProteinsGsk3b protein, mouseLef1 protein, mouseLymphoid Enhancer-Binding Factor 1Wnt Proteins

Identifiers

PMID20146356
PMCPMC3399184
OpenAlexW1992275154

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.